Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood

G. Zauli, L. Valvassori, S. Capitani

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The in vitro growth of early (burst-forming unit-megakaryocyte [BFU-meg]) and late (colony-forming unit-megakaryocyte [CFU-meg]) megakaryocyte progenitors was investigated in midtrimester human fetal blood and compared with adult bone marrow. Most of the experiments were performed in a serum- free fibrinclot assay, using purified hematopoietic progenitor (CD34+) cells. High BFU-meg and CFU-meg levels were found in human fetal blood, with a clear prevalence of BFU-meg (BFU-meg:CFU-meg ratio, 2.5:1), at variance with adult bone marrow, in which mature CFU-meg predominate (BFU-meg:CFU-meg ratio, 0.6:1). Fetal and adult megakaryocyte progenitors had a similar phenotypic profile for the expression of CD34, HLA-DR, and glycoprotein- complex IIB-IIIA. However, fetal BFU-meg were larger in size (number of megakaryocytic elements per colony) than adult BFU-meg, but were usually composed by only one or two foci of development. On the other hand, fetal and adult CFU-meg were similar in both morphology and size. Fetal megakaryocyte progenitors appeared earlier in culture and had an increased proliferative activity as demonstrated by the higher number of megakaryocyte progenitors in S phase with respect to adult CFU-meg and BFU-meg. Finally, fetal megakaryocyte progenitors displayed a higher sensitivity to stimulatory cytokines, in particular recombinant interleukin-3, than adult megakaryocyte progenitors, whereas they were inhibited by purified transforming growth factor-β1 in a similar fashion to adult megakaryocyte progenitors.

Original languageEnglish
Pages (from-to)385-390
Number of pages6
JournalBlood
Volume81
Issue number2
Publication statusPublished - 1993

Fingerprint

Megakaryocyte Progenitor Cells
Megakaryocytes
Fetal Blood
Bone
Blood
Interleukin-3
Transforming Growth Factors
HLA-DR Antigens
Assays
Glycoproteins
Stem Cells
Cytokines
Experiments
Bone Marrow

ASJC Scopus subject areas

  • Hematology

Cite this

Zauli, G., Valvassori, L., & Capitani, S. (1993). Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. Blood, 81(2), 385-390.

Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. / Zauli, G.; Valvassori, L.; Capitani, S.

In: Blood, Vol. 81, No. 2, 1993, p. 385-390.

Research output: Contribution to journalArticle

Zauli, G, Valvassori, L & Capitani, S 1993, 'Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood', Blood, vol. 81, no. 2, pp. 385-390.
Zauli, G. ; Valvassori, L. ; Capitani, S. / Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. In: Blood. 1993 ; Vol. 81, No. 2. pp. 385-390.
@article{48a7a22c5eb84c67993b504691b4d38b,
title = "Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood",
abstract = "The in vitro growth of early (burst-forming unit-megakaryocyte [BFU-meg]) and late (colony-forming unit-megakaryocyte [CFU-meg]) megakaryocyte progenitors was investigated in midtrimester human fetal blood and compared with adult bone marrow. Most of the experiments were performed in a serum- free fibrinclot assay, using purified hematopoietic progenitor (CD34+) cells. High BFU-meg and CFU-meg levels were found in human fetal blood, with a clear prevalence of BFU-meg (BFU-meg:CFU-meg ratio, 2.5:1), at variance with adult bone marrow, in which mature CFU-meg predominate (BFU-meg:CFU-meg ratio, 0.6:1). Fetal and adult megakaryocyte progenitors had a similar phenotypic profile for the expression of CD34, HLA-DR, and glycoprotein- complex IIB-IIIA. However, fetal BFU-meg were larger in size (number of megakaryocytic elements per colony) than adult BFU-meg, but were usually composed by only one or two foci of development. On the other hand, fetal and adult CFU-meg were similar in both morphology and size. Fetal megakaryocyte progenitors appeared earlier in culture and had an increased proliferative activity as demonstrated by the higher number of megakaryocyte progenitors in S phase with respect to adult CFU-meg and BFU-meg. Finally, fetal megakaryocyte progenitors displayed a higher sensitivity to stimulatory cytokines, in particular recombinant interleukin-3, than adult megakaryocyte progenitors, whereas they were inhibited by purified transforming growth factor-β1 in a similar fashion to adult megakaryocyte progenitors.",
author = "G. Zauli and L. Valvassori and S. Capitani",
year = "1993",
language = "English",
volume = "81",
pages = "385--390",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood

AU - Zauli, G.

AU - Valvassori, L.

AU - Capitani, S.

PY - 1993

Y1 - 1993

N2 - The in vitro growth of early (burst-forming unit-megakaryocyte [BFU-meg]) and late (colony-forming unit-megakaryocyte [CFU-meg]) megakaryocyte progenitors was investigated in midtrimester human fetal blood and compared with adult bone marrow. Most of the experiments were performed in a serum- free fibrinclot assay, using purified hematopoietic progenitor (CD34+) cells. High BFU-meg and CFU-meg levels were found in human fetal blood, with a clear prevalence of BFU-meg (BFU-meg:CFU-meg ratio, 2.5:1), at variance with adult bone marrow, in which mature CFU-meg predominate (BFU-meg:CFU-meg ratio, 0.6:1). Fetal and adult megakaryocyte progenitors had a similar phenotypic profile for the expression of CD34, HLA-DR, and glycoprotein- complex IIB-IIIA. However, fetal BFU-meg were larger in size (number of megakaryocytic elements per colony) than adult BFU-meg, but were usually composed by only one or two foci of development. On the other hand, fetal and adult CFU-meg were similar in both morphology and size. Fetal megakaryocyte progenitors appeared earlier in culture and had an increased proliferative activity as demonstrated by the higher number of megakaryocyte progenitors in S phase with respect to adult CFU-meg and BFU-meg. Finally, fetal megakaryocyte progenitors displayed a higher sensitivity to stimulatory cytokines, in particular recombinant interleukin-3, than adult megakaryocyte progenitors, whereas they were inhibited by purified transforming growth factor-β1 in a similar fashion to adult megakaryocyte progenitors.

AB - The in vitro growth of early (burst-forming unit-megakaryocyte [BFU-meg]) and late (colony-forming unit-megakaryocyte [CFU-meg]) megakaryocyte progenitors was investigated in midtrimester human fetal blood and compared with adult bone marrow. Most of the experiments were performed in a serum- free fibrinclot assay, using purified hematopoietic progenitor (CD34+) cells. High BFU-meg and CFU-meg levels were found in human fetal blood, with a clear prevalence of BFU-meg (BFU-meg:CFU-meg ratio, 2.5:1), at variance with adult bone marrow, in which mature CFU-meg predominate (BFU-meg:CFU-meg ratio, 0.6:1). Fetal and adult megakaryocyte progenitors had a similar phenotypic profile for the expression of CD34, HLA-DR, and glycoprotein- complex IIB-IIIA. However, fetal BFU-meg were larger in size (number of megakaryocytic elements per colony) than adult BFU-meg, but were usually composed by only one or two foci of development. On the other hand, fetal and adult CFU-meg were similar in both morphology and size. Fetal megakaryocyte progenitors appeared earlier in culture and had an increased proliferative activity as demonstrated by the higher number of megakaryocyte progenitors in S phase with respect to adult CFU-meg and BFU-meg. Finally, fetal megakaryocyte progenitors displayed a higher sensitivity to stimulatory cytokines, in particular recombinant interleukin-3, than adult megakaryocyte progenitors, whereas they were inhibited by purified transforming growth factor-β1 in a similar fashion to adult megakaryocyte progenitors.

UR - http://www.scopus.com/inward/record.url?scp=0027390179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027390179&partnerID=8YFLogxK

M3 - Article

C2 - 7678515

AN - SCOPUS:0027390179

VL - 81

SP - 385

EP - 390

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -